Bio-Techne Corp (TECH)

Currency in USD
63.82
+0.87(+1.38%)
Closed·
63.67-0.15(-0.24%)
·

TECH Earnings

Latest Release
Nov 05, 2025
EPS / Forecast
0.42 / 0.4213
Revenue / Forecast
286.56M / 291.47M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
12/2025--/0.436--/291.18M----Free Sign Up
09/20250.42/0.421286.56M/291.47M-0.31%-1.68%Free Sign Up
06/2025-0.12/0.5316.96M/315.54M-124%+0.45%Free Sign Up
03/20250.14/0.51316.18M/317.51M-72.55%-0.42%Free Sign Up
12/20240.42/0.39297M/286.14M+7.69%+3.8%Free Sign Up
09/20240.42/0.38289.5M/280.22M+10.53%+3.31%Free Sign Up
06/20240.49/0.5306.1M/306.47M-2%-0.12%Free Sign Up
03/20240.48/0.45303.4M/292.91M+6.67%+3.58%Free Sign Up
12/20230.4/0.41272.6M/277.55M-2.44%-1.78%Free Sign Up
09/20230.41/0.43276.9M/287.66M-4.65%-3.74%Free Sign Up

All numbers in USD

Bio-Techne Corp Earnings Call Summary for Q1/2026

  • Bio-Techne reported Q1 2025 EPS of $0.42 and revenue of $286.6M, missing forecasts and causing a 12.85% stock drop in pre-market trading.
  • North American revenue declined mid-single digits while Europe and Asia saw low single-digit growth; adjusted operating margin improved 90 basis points to 29.9%.
  • Management forecasts low single-digit growth for fiscal 2026 with positive organic growth in H2, expecting Q2 performance similar to Q1.
  • The company continues product innovation with ProximityScope and ultra-sensitive Ella cartridge launches while achieving 40% emissions reduction.
  • CEO Kim Kelderman expressed confidence in future growth despite current biotech funding challenges and regional revenue declines.
Last Updated: 05/11/2025, 17:16
Read Full Transcript

FAQ

What Is Bio-Techne's Earnings Per Share (TTM)?

The Bio-Techne EPS (TTM) is 0.49.

When Is The Next Bio-Techne Earnings Date?

Bio-Techne will release its next earnings report on 02 Feb 2026.

What Is Bio-Techne’s Revenue Forecasts For Upcoming Quarters?

Bio-Techne’s revenue forecast is 291.18M.

How Did Bio-Techne React to the Company's Latest Earnings Report?

Bio-Techne reported a -0.31%% EPS surprise and a -1.68%% revenue surprise, comparing the latest report against analyst forecasts. The stock price changed by -4.78%%, reflecting the market's response to the earnings results.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.